Contracting an in-country clinical depot helps bring costs and timelines under control.
In patient support programs, success—and your ROI—rests on making that vital connection between technology and the human touch.
Exposure and dose response analyses, including pharmacokinetic and pharmacodynamics analyses, guide critical decisions in drug development. Cytel’s expert Quantitative Pharmacology and Pharmacometrics group helps our customers get those decisions right.
ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specializes in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 97 locations in 38 countries and has approximately 13,100 employees.
Gain a competitive advantage for your study in the ever-evolving landscape of hematology and oncology drug and biologic clinical development.
For more than 20 years, Bellwyck has been a true partner in developing smarter solutions for the pharmaceutical industry — from clinical trial to commercialization. We utilize cost-efficient packaging strategies to launch clinical studies on time, every time. Discover all of the ways in which Bellwyck might assist you in meeting your unique objectives.
We believe that expert statistical input has the power to shape the future of clinical development: de-risking portfolios, accelerating timelines, and increasing the probability of success.
A hands-on approach provides significant advantages that can shorten drug development timelines and reduce development risk.
In order to demonstrate a deeper commitment to clinical trial transparency than the law requires, some sponsors are choosing to provide additional information about their portfolio of clinical trials on a dedicated website. TrialScope Engage can help sponsors manage clinical trial content that is being prepared for disclosure on their own sites.
Whether you have a large, complex global study or need a small, regional solution, we can reliably supply your clinical trial anywhere in the world. From Phase I to Phase III and beyond, we are the catalyst for your success.
|
|
|
|
|
|
|
|
|